Cooper Companies (NASDAQ:COO) Releases Earnings Results, Beats Estimates By $0.07 EPS

Cooper Companies (NASDAQ:COO) issued its quarterly earnings results on Thursday. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.03 by $0.07, FiscalAI reports. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter last year, the business posted $0.92 EPS. Cooper Companies’s quarterly revenue was up 6.2% compared to the same quarter last year. Cooper Companies updated its Q2 2026 guidance to 4.580-4.660 EPS.

Here are the key takeaways from Cooper Companies’ conference call:

• Cooper reported a strong quarter with non‑GAAP EPS up 20% to $1.10, $159M of free cash flow, and raised full‑year guidance to $4.58–$4.66 EPS and $600–$625M free cash flow.
• CooperVision continued product‑led share gains (18th consecutive year), driven by the MyDay premium portfolio and MiSight (MiSight sales up 23%), plus multiple new branded and private‑label contract wins and global rollouts.
• Asia‑Pacific disappointed, led by softness in Japan from legacy hydrogel products; management expects APAC to remain down in Q2 and recover by fiscal Q3, creating near‑term revenue risk.
• Organizational changes, IT/AI implementations and cost synergies lifted margins (gross margin 68.1%, operating income +13.9%) and are funding reinvestment in sales/marketing, buybacks ($92M repurchased) and debt reduction.
• CooperSurgical showed early fertility market recovery and solid surgical product trends, but exposure to the Middle East (~2% of sales) and uncertain timing of equipment installations leave near‑term visibility mixed.

Cooper Companies Stock Down 2.2%

COO stock opened at $80.20 on Friday. The stock has a 50-day simple moving average of $82.23 and a two-hundred day simple moving average of $75.95. Cooper Companies has a twelve month low of $61.78 and a twelve month high of $91.59. The firm has a market capitalization of $15.65 billion, a PE ratio of 42.66, a PEG ratio of 2.34 and a beta of 1.02. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30.

Insider Buying and Selling

In other news, Director Cynthia L. Lucchese acquired 1,784 shares of Cooper Companies stock in a transaction that occurred on Monday, December 22nd. The stock was bought at an average price of $84.06 per share, with a total value of $149,963.04. Following the completion of the purchase, the director owned 9,445 shares in the company, valued at approximately $793,946.70. The trade was a 23.29% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Lawrence Erik Kurzius bought 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The shares were purchased at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the acquisition, the director directly owned 7,777 shares in the company, valued at $641,602.50. This trade represents a 34.62% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 16,014 shares of company stock valued at $1,304,416 in the last three months. Insiders own 2.08% of the company’s stock.

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors have recently added to or reduced their stakes in the business. Advisory Services Network LLC purchased a new stake in Cooper Companies in the third quarter valued at approximately $163,000. Siemens Fonds Invest GmbH increased its holdings in shares of Cooper Companies by 22.0% in the 3rd quarter. Siemens Fonds Invest GmbH now owns 2,782 shares of the medical device company’s stock worth $191,000 after buying an additional 502 shares during the last quarter. Nicolet Advisory Services LLC bought a new position in shares of Cooper Companies in the 3rd quarter worth $210,000. Mangrove Partners IM LLC purchased a new stake in shares of Cooper Companies during the 3rd quarter valued at $594,000. Finally, American Trust bought a new stake in shares of Cooper Companies during the 4th quarter worth $216,000. 24.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on COO shares. William Blair raised Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Barclays set a $98.00 price objective on Cooper Companies and gave the stock an “overweight” rating in a report on Monday, January 26th. Wells Fargo & Company upped their price objective on shares of Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a report on Friday, December 5th. Mizuho set a $100.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Friday, December 5th. Finally, Piper Sandler reissued an “overweight” rating and issued a $94.00 price target (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.50.

Key Stories Impacting Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Company raised full‑year 2026 EPS and free‑cash‑flow guidance, citing strong momentum for MyDay and MiSight contact‑lens franchises — a clear upside catalyst for revenue and cash generation expectations. Article Title
• Positive Sentiment: Q1 results beat EPS estimates: reported $1.10 EPS vs. ~ $1.03 consensus; revenue roughly $1.02B (+6.2% YoY) with improved margins and stronger operating cash flow — supports the raised guidance. Press Release
• Positive Sentiment: Product/clinical momentum: CooperVision highlighted research at NCC 2026 supporting long‑term comfort and wear for contact lenses — bolsters competitive positioning for MyDay/MiSight adoption. PR
• Positive Sentiment: Insider buying activity flagged by data services (multiple recent insider purchases) — can be read as management confidence in outlook. QuiverQuant
• Neutral Sentiment: Full earnings call transcript and slide deck released — useful for investors who want line‑by‑line detail on regional trends, product growth and cadence of guidance. Transcript
• Neutral Sentiment: Investing press pieces highlight a strategic‑review focus at the company — could signal future capital allocation or portfolio moves but timing/impact are uncertain. Investing.com
• Negative Sentiment: Rothschild & Co Redburn downgraded COO from Buy to Neutral with an $85 price target — an analyst downgrade that can pressure the stock despite the outlook upgrade. Finviz

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.